These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2979827)

  • 1. Flow cytometry in invasive endometrial carcinoma. Correlations between DNA content S-phase rate and clinical parameters.
    Stendahl U; Wagenius G; Strang P; Tribukait B
    In Vivo; 1988; 2(2):123-7. PubMed ID: 2979827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age, menopausal status and DNA-content in endometrial adenocarcinoma.
    Strang P; Stendahl U; Tribukait B; Wagenius G; Boman K
    Anticancer Res; 1989; 9(4):1079-82. PubMed ID: 2817789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
    Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
    Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of oestrogen on growth of endometrial carcinoma.
    Boman K; Strang P; Bäckström T; Gerdes U; Stendahl U
    Anticancer Res; 1990; 10(1):173-6. PubMed ID: 2334123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual myometrial invasion after intracavitary irradiation of endometrial adenocarcinoma stages I and II. Relations to DNA content and S-phase rate.
    Wagenius G; Strang P; Boman K; Tribukait B; Stendahl U
    In Vivo; 1988; 2(3-4):243-5. PubMed ID: 2979839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometrical DNA- and clinical parameters in the prediction of prognosis in stage I-II endometrial carcinoma.
    Lindahl B; Gullberg B
    Anticancer Res; 1991; 11(1):397-401. PubMed ID: 2018376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix.
    Strang P; Eklund G; Stendahl U; Frankendal B
    Anticancer Res; 1987; 7(4B):807-10. PubMed ID: 3674766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
    Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
    Friberg LG; Norén H; Delle U
    Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
    Lindahl B; Alm P; Killander D; Långström E; Tropé C
    Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in DNA content and proliferation rate between adenocarcinomas of the uterine cervix and corpus.
    Strang P; Stendahl U; Lindgren A; Sténson S
    In Vivo; 1987; 1(2):109-12. PubMed ID: 2979770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic significance of cell kinetic parameters of endometrial cancer].
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Abel U; Heep J; von Minckwitz G
    Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):787-92. PubMed ID: 2806852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
    Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indices in endometrial adenocarcinoma stages I and II. A study based on clinical, histopathological and flow cytometric variables.
    Wagenius G; Strang P; Bergström R; Stendahl U; Tribukait B
    Anticancer Res; 1991; 11(6):2137-42. PubMed ID: 1776852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.